Scholars Central

Research articlePublished 3 May 2019

Osteopathic manual therapy (OMT) in treatment of gastroesophageal reflux disease (GERD)

Authors: Kjell E Bjornaes, Geir Elvbakken, Bård Dalhoi, Tor Harald Garberg, Joachim Kaufmann, Espen Glomsrod, Ola Reiertsen, Stig Larsen

Clinical Practice

Volume 16 · Issue 3 · Pages 1109–1115

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Osteopathic Manual Therapy (OMT) is a non-pharmaceutical and none-invasive treatment, designed to treat Gastroesophageal Reflux Disease (GERD). The aims were to determine a Minimum Efficacy Dose (MED) and the longterm effect of OMT in the treatment of GERD. Materials and method: The study was performed as a two-dimensional, between-patient Response Surface Pathway (RSP) designed multicenter study with “Number of OMTs” and “Treatment Interval” as interventional variables. The main response variable was the percent reduction in the sum of the five GERD-scores from baseline. Three patients on the first design level received six OMT with five days’ interval. The number of OMTs and treatment interval in the second (n=5) and third design levels (n=7) were based on the results of the previous design level. The mean age and duration of GERD were 50.2 and 10.9 years, ranging from 25.7 to 75.7 years and 0.2 to 36.3 years, respectively. Results: The percent reduction in GERD-score increased with increasing number of OMTs and time intervals, but flattered out after four OMTs and three to four days treatment interval. The estimated MED of OsMT was three treatments with two days interval resulting in a GERD-score reduction of 62.2% (95% CI: 50.3-80.1%). All the five GERD-symptoms and consequently the mean GERD-score were significantly reduced after the first two OMTs, one week, three and 12 months after the last treatment (p<<0.01). One week after last OMT, the GERD-score reduced with 75% and 33% symptoms free patients. At one-year follow-up, the reduction was 63.3% with 46.7% had no GERD-symptoms. Conclusion: Anti-reflux OMT significantly decreases the GERD-symptoms and the use of PPI. 46.7 percent of the patents had no GERD symptoms one year after treatment. The estimated MED of OMT was three treatments with two days (48 hours) interval.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Practice.

All its articles

Article · 28 Mar 2025

Using

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Practice
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Kjell E Bjornaes”
  • BylineArticles whose byline prints “Geir Elvbakken”
  • BylineArticles whose byline prints “Bård Dalhoi”
  • BylineArticles whose byline prints “Tor Harald Garberg”
  • BylineArticles whose byline prints “Joachim Kaufmann”
  • BylineArticles whose byline prints “Espen Glomsrod”
  • BylineArticles whose byline prints “Ola Reiertsen”
  • BylineArticles whose byline prints “Stig Larsen”